Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: A novel model for studying the pathomechanisms of inflammatory bowel disease cytokines

Scandinavian Journal of Gastroenterology

Volumn 44, Issue 10, 2009, Pages 1226-1235

  Amasheh, Maren ^a   Grotjohann, Ingo ^b   Amasheh, Salah ^b   Fromm, Anja ^a,b   Söderholm, Johan D ^c   Zeitz, Martin ^a   Fromm, Michael ^b   Schulzke, Jrg Dieter ^b  

^a Infectious Diseases and Rheumatology   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Barrier function; Claudins; Colon; Crypts; Cytokines; Interferon ; Large intestine; Mucosal structure; Occludin; Permeability; Tight junctions; Transepithelial resistance; Tumor necrosis factor

Indexed keywords

CLAUDIN 1; CLAUDIN 2; CLAUDIN 5; CLAUDIN 7; GAMMA INTERFERON; HORSERADISH PEROXIDASE; MANNITOL; OCCLUDIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENTERITIS; IMMUNOBLOTTING; INTESTINE ABSORPTION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TIGHT JUNCTION; TRANSCYTOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; INFLAMMATORY BOWEL DISEASES; INTERFERON-GAMMA; INTESTINAL MUCOSA; MALE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350648021     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520903131973     Document Type: Article

References (58)

1. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998;/141:/1539-50.
2. Anderson JM, Van Itallie CM. Tight Junctions. Curr Biol 2008;/18:/941-3.
3. Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 2003;/18:/479-97.
4. Bü rgel N, Bojarski C, Mankertz J, Zeitz M, Fromm M, Schulzke JD. Mechanisms of diarrhea in collagenous colitis. Gastroenterology 2002;/123:/433-43.
5. Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, Mankertz J, et al. Tumor necrosis factor-alpha (TNF-alpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 1999;/112:/137-6.
6. Schü rmann G, Brüwer M, Klotz A, Schmid KW, Senninger N, Zimmer KP. Transepithelial transport processes at the intestinal mucosa in inflammatory bowel disease. Int J Colorectal Dis 1999;/14:/41-6.
7. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-gamma and tumor necrosis factoralpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 2005;/166:/409-9.
8. Garside P, Bunce C, Tomlinson RC, Nichols BL, Mowat AM. Analysis of enteropathy induced by tumour necrosis factor alpha. Cytokine 1993;/5:/24-30.
9. Guy-Grand D, DiSanto JP, Henchoz P, Malassis-Séris M, Vassalli P. Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-gamma, TNF) in the induction of epithelial cell death and renewal. Eur J Immunol 1998;/8:/730-4.
10. Gitter AH, Bendfeldt K, Schulzke JD, Fromm M. Leaks in the epithelial barrier caused by spontaneous and TNFalpha- induced single-cell apoptosis. Faseb J 2000;/4:/1749-3.
11. Mankertz J, Tavalali S, Schmitz H, Mankertz A, Riecken EO, Fromm M, et al. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J Cell Sci 2000;/13:/2085-90.
12. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003;/71:/6164-2.
13. Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, MacDonald TT, et al. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 2005;/85:/1139-62.
14. Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, Mrsny RJ, et al. Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 2005;/16:/5040-52.
15. Ma TY, Boivin MA, Ye D, Pedram A, Said HM. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 2005;/288:/G422-30.
16. Ye D, Ma I, Ma TY.Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2006;/290:/ G496-504.
17. Wang F, Schwarz BT, Graham WV, Wang Y, Su L, Clayburgh DR, et al. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 2006;/131:/1153-63.
18. Gitter AH, Wullstein F, Fromm M, Schulzke JD. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 2001;/121:/1320-8.
19. Suenaert P, Bulteel V, Lemmens L, Noman M, Geypens B, Van Assche G, et al. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am J Gastroenterol 2002;/97:/2000-4.
20. Zeissig S, Bojarski C, Buergel N, Mankertz J, Zeitz M, Fromm M. Down-regulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 2004;/53:/1295-302.
21. Barrett KE. Immune-related intestinal chloride secretion. III. Acute and chronic effects of mast cell mediators on chloride secretion by a human colonic epithelial cell line. J Immunol 1991;/147:/959-64.
22. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005;/129:/550-64.
23. Cooke HJ. Neuroimmune signaling in regulation of intestinal ion transport. Am J Physiol 1994;/266:/G167-78.
24. Powell DW, Adegboyega PA, Di Mari JF, Mifflin RC. Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. Am J Physiol Gastrointest Liver Physiol 2005;/289:/G2-7.
25. Grotjohann I, Schulzke JD, Fromm M. Electrogenic Na- transport in rat late distal colon by natural and synthetic glucocorticosteroids. Am J Physiol 1999;/276:/G491-8.
26. Fromm M, Schulzke JD, Hegel U. Control of electrogenic Na- absorption in rat late distal colon by nanomolar aldosterone added in vitro. Am J Physiol 1993;/264:/E68-73.
27. Schulzke JD, Fromm M, Bentzel CJ, Zeitz M, Menge H, Riecken EO. Ion transport in the experimental short bowel syndrome of the rat. Gastroenterology 1992;/102:/497-504.
28. Tai YH, Tai CY. The conventional short-circuiting technique under-short-circuits most epithelia. J Membr Biol 1981;/59:/ 173-7.
29. Schulzke JD, Fromm M, Menge H, Riecken EO. Impaired intestinal sodium and chloride transport in the blind loop syndrome of the rat. Gastroenterology 1987;/92:/693-8.
30. Santos J, Yang PC, Söderholm JD, Benjamin M, Perdue MH. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001;/48:/630-6.
31. Dawson DC. Na and Cl transport across the isolated turtle colon: parallel pathways for transmural ion movement. J Membr Biol 1977;/37:/213-33.
32. Rahner C, Mitic LL, Anderson JM. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 2001;/120:/411-22.
33. Barmeyer C, Harren M, Schmitz H, Heinzel-Pleines U, Mankertz J, Seidler U, et al. Mechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation. Am J Physiol Gastrointest Liver Physiol 2004;/286:/ G244-52.
34. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 1999;/116:/301-9.
35. Sanders DS. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease. J Clin Pathol 2005;/58:/568-72.
36. Madara JL, Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989;/83:/724-7.
37. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 2004;/286:/ G367-76.
38. Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 2000;/ 279:/G851-7.
39. Amasheh S, Schmidt T, Mahn M, Florian P, Mankertz J, Tavalali S, et al. Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells. Cell Tissue Res 2005;/321:/89-96.
40. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin- 1-deficient mice. J Cell Biol 2002;/156:/1099-111.
41. Amasheh S, Meiri N, Gitter AH, Schöneberg T, Mankertz J, Schulzke JD, et al. Claudin-2 expression induces cationselective channels in tight junctions of epithelial cells. J Cell Sci 2002;/115:/4969-76.
42. Alexandre MD, Lu Q, Chen YH. Overexpression of claudin- 7 decreases the paracellular Cl- conductance and increases the paracellular Na- conductance in LLC-PK1 cells. J Cell Sci 2005;/118:/2683-93.
43. Poritz LS, Garver KI, Tilberg AF, Koltun WA. Tumor necrosis factor alpha disrupts tight junction assembly. J Surg Res 2004;/116:/14-8.
44. Bruewer M, Utech M, Ivanov AI, Hopkins AM, Parkos CA, Nusrat A. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. Faseb J 2005;/19:/923-33.
45. Ivanov AI, Nusrat A, Parkos CA. Endocytosis of the apical junctional complex: mechanisms and possible roles in regulation of epithelial barriers. Bioessays 2005;/27:/356-65.
46. Ivanov AI, Nusrat A, Parkos CA. The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novartis Found Symp 2004;/263:/115-24.
47. Gassler N, Rohr C, Schneider A, Kartenbeck J, Bach A, Obermü ller N, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001;/281:/G216-28.
48. Hollander D. Crohn's disease: a permeability disorder of the tight junction? Gut 1988;/29:/1621-4.
49. Bojarski C, Gitter AH, Bendfeldt K, Mankertz J, Schmitz H, Wagner S, et al. Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J Physiol 2001;/535:/ 541-52.
50. Kersting S, Bruewer M, Schuermann G, Klotz A, Utech M, Hansmerten M, et al. Antigen transport and cytoskeletal characteristics of a distinct enterocyte population in inflammatory bowel diseases. Am J Physiol 2004;/165:/425-37.
51. Salik E, Tyorkin M, Mohan S, George I, Becker K, Oei E, et al. Antigen trafficking and accessory cell function in respiratory epithelial cells. Am J Respir Cell Mol Biol 1999;/ 21:/365-79.
52. Martinez I, Sveinbjørnsson B, Vidal-Vanaclocha F, Asumendi A, Smedsrød B. Differential cytokine-mediated modulation of endocytosis in rat liver endothelial cells. Biochem Biophys Res Commun 1995;/212:/235-41.
53. Söderholm JD, Streutker C, Yang PC, Paterson C, Singh PK, McKay DM, et al. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor a. Gut 2004;/53:/1817-24.
54. Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992;/339:/89-91.
55. Van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut 1997;/40:/443-8.
56. Van Dullemen HM, de Jong E, Slors F, Tytgat GN, van Deventer SJ. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;/109:/129-35.
57. Zeissig S, Bü rgel N, Gü nzel D, Richter J, Mankertz J, Wahnschaffe U, et al. Changes in expression and distribution of claudin-2, -5 and -8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007;/ 56:/61-72.
58. Pender SL, Tickle SP, Docherty AJ, Howie D, Wathen NC, MacDonald TT. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997;/158:/1582-90.